1.World Health Organization (2016) Combating Hepatitis B and C to Reach Elimination by 2030. Geneva.
2.World Health Organization (2017) Hepatitis C Fact Sheet. Geneva.
3.World Health Organization (2016) In: Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva. .
4.Shahid, I et al. (2017) Real-world challenges for hepatitis C virus medications: a critical overview. Critical Revies in Microbiology 44, 1–18.
5.Polaris Observatory HCV Collaborators (2017) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterology and Hepatology 2, 161–176.
6.Sievert, W et al. (2011) A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver International 31(suppl. 2), 61–80.
7.Goel, A, Seguy, N and Aggarwal, R (2018) Burden of hepatitis C virus infection in India: a systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 34, 321–329.
8.World Health Organization (2018) Progress Report on Access to Hepatitis C Treatment. Geneva.
9.Love, J (2011) The production of generic drugs in India. British Medical Journal 342, d1694.
10.Census India (2011) Punjab State Census 2011. Punjab.
11.The Indian Express (2016) Punjab: Government Launches Special Fund for Free Treatment of Hepatitis C. Chandigarh.
12.Sood, A et al. (2018) The burden of hepatitis C virus infection in Punjab, India: a population-based serosurvey. PLoS ONE 13, e0200461.
13.Zampino, R et al. (2015) Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment. World Journal of Hepatology 7, 2323–2330.
14.Janjua, NZ, Mahmood, B and Imran Khan, M (2014) Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan? Journal of Infection and Public Health 7, 345–355.
15.Dhiman, RK et al. (2016) Tackling the hepatitis C disease burden in Punjab, India. Journal of Clinical and Experimental Hepatology 6, 224–232.
16.Basu, D (2010) Overview of substance abuse and hepatitis C virus infection and co-infections in India. Journal of Neuroimmune Pharmacology 5, 496–506.
17.Panda, S et al. (2014) Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates. International Journal of STD & AIDS 25, 596–606.
18.National AIDS Control Organisation (2012) District Epidemiological Profiling Using Data Triangulation Fact Sheets, Vol. 1. New Delhi, India.
19.UNAIDS, Ambekar, A and Tripathi, B (2008) Size Estimation of Injecting Drug Use in Punjab & Haryana. New Delhi, India: UNAIDS.
20.Drug and Alcohol Rehab in Thailand. .
21.Topp, L et al. (2013) Housing instability among people who inject drugs: results from the Australian Needle and Syringe Program Survey. Journal of Urban Health-Bulletin of the New York Academy of Medicine 90, 699–716.
22.Indolfi, G, Nesi, A and Resti, M (2013) Intrafamilial transmission of hepatitis C virus. Journal of Medical Virology 85, 608–614.
23.Ackerman, Z, Ackerman, E and Paltiel, O (2000) Intrafamilial transmission of hepatitis C virus: a systematic review. Journal of Viral Hepatitis 7, 93–103.
24.Lankarani, KB et al. (2016) Evaluation of hepatitis C virus intrafamilial transmission among families with one index case, a pilot study from Fars province, Iran. Gastroenterology and Hepatology from Bed to Bench 9, 250–258.
25.Brusaferro, S et al. (1999) A study on the role of the family and other risk factors in HCV transmission. European Journal of Epidemiology 15, 125–132.
26.Kim, YS et al. (1998) Lack of familial clustering of hepatitis C virus infection. International Journal of Epidemiology 27, 525–529.
27.Vegnente, A et al. (1994) Lack of intrafamilial transmission of hepatitis C virus in family members of children with chronic hepatitis c infection. The Pediatric Infectious Disease Journal 13, 886–889.
28.Kim, YS, Ahn, YO and Kim, DW (1994) Familial clustering of hepatitis B and C viruses in Korea. Journal of Korean Medical Science 9, 444–449.
29.Demelia, L et al. (1996) HCV transmission in family members of subjects with HCV related chronic liver disease. European Journal of Epidemiology 12, 45–50.
30.Wasitthankasem, R et al. (2017) Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence. PLoS ONE 12, e0177022.
31.Vermeiren, AP et al. (2012) Identification of hidden key hepatitis C populations: an evaluation of screening practices using mixed epidemiological methods. PLoS ONE 7, e51194.
32.Umer, M and Iqbal, M (2016) Hepatitis C virus prevalence and genotype distribution in Pakistan: comprehensive review of recent data. World Journal of Gastroenterology 22, 1684–1700.
33.Trickey, A et al. (2017) Importance and contribution of community, social, and healthcare risk factors for hepatitis C infection in Pakistan. American Journal of Tropical Medicine and Hygiene 97, 1920–1928.
34.Pasha, O et al. (1999) Household members of hepatitis C virus-infected people in Hafizabad, Pakistan: infection by injections from health care providers. Epidemiology & Infection 123, 515–518.
35.Prabhu, S et al. (2010) Prevalence, nature, context and impact of alcohol use in India: recommendations for practice and research. Brown School Faculty Publications.
36.Omar, MZ et al. (2017) Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt. Hepatic Medicine 9, 27–33.